Julie Harriague

Julie Harriague

Auto-generated profile, based on publicly available information

Julie Harriague

Clinics, Paris, France

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KBKarl Balabanian
Karl Balabanian
BLBernard Lagane
Bernard Lagane
SISimona Infantino
Simona Infantino
KCKen Y. C. Chow
Ken Y. C. Chow
JHJulie Harriague
Julie Harriague
FBFrançoise Bachelerie
Françoise Bachelerie
Combined phylogenetic and chromosomal location studies suggest that the orphan receptor RDC1 is related to CXC chemokine receptors. RDC1 provides a co-receptor function for a restricted number of human immunodeficiency virus (HIV) isolates, in particular for the CXCR4-using HIV-2 ROD strain. Here we show that CXCL12, the only known natural ligand for CXCR4, binds to and signals through RDC1. We demonstrate that RDC1 is expressed in T lymphocytes and that CXCL12-promoted chemotaxis is inhibited by an anti-RDC1 monoclonal antibody. Concomitant blockade of RDC1 and CXCR4 produced additive inhibitory effects in CXCL12-induced T cell migration. Furthermore, we provide evidence that interaction of CXCL12 with RDC1 is specific, saturable, and of high affinity (apparent KD ≈ 0.4 nm). In CXCR4-negative cells expressing RDC1, CXCL12 promotes internalization of the receptor and chemotactic signals through RDC1. Collectively, our data indicate that RDC1, which we propose to rename as CXCR7, is a receptor for CXCL12.

1 June 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Pierre-Yves LozachPierre-Yves Lozach
Pierre-Yves Lozach
LBLaura Burleigh
Laura Burleigh
ISIsabelle Staropoli
Isabelle Staropoli
ENErika Navarro-Sanchez
Erika Navarro-Sanchez
JHJulie Harriague
Julie Harriague
AAAli Amara
Ali Amara
Dengue virus (DV) is a mosquito-borne flavivirus that causes hemorrhagic fever in humans. In the natural infection, DV is introduced into human skin by an infected mosquito vector where it is believed to target immature dendritic cells (DCs) and Langerhans cells (LCs). We found that DV productively infects DCs but not LCs. We show here that the interactions between DV E protein, the sole mannosylated glycoprotein present on DV particles, and the C-type lectin dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) are essential for DV infection of DCs. Binding of mannosylated N-glycans on DV E protein to DC-SIGN triggers a rapid and efficient internalization of the viral glycoprotein. However, we observed that endocytosis-defective DC-SIGN molecules allow efficient DV replication, indicating that DC-SIGN endocytosis is dispensable for the internalization step in DV entry. Together, these results argue in favor of a mechanism by which DC-SIGN enhances DV entry and infection in cis. We propose that DC-SIGN concentrates mosquito-derived DV particles at the cell surface to allow efficient interaction with an as yet unidentified entry factor that is ultimately responsible for DV internalization and pH-dependent fusion into DCs.

1 July 2008 in Blood
Verified
Journal Article
Closed access
PDF file
BLBernard Lagane
Bernard Lagane
KCKen Y C Chow
Ken Y C Chow
KBKarl Balabanian
Karl Balabanian
ALAngelique Levoye
Angelique Levoye
JHJulie Harriague
Julie Harriague
FBFrançoise Bachelerie
Françoise Bachelerie
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is an immune deficiency linked in many cases to heterozygous mutations causing truncations in the cytoplasmic tail of CXC chemokine receptor 4 (CXCR4). Leukocytes expressing truncated CXCR4 display enhanced responses to the receptor ligand CXCL12, including chemotaxis, which likely impair their trafficking and contribute to the immunohematologic clinical manifestations of the syndrome. CXCR4 desensitization and endocytosis are dependent on β-arrestin (βarr) recruitment to the cytoplasmic tail, so that the truncated CXCR4 are refractory to these processes and so have enhanced G protein–dependent signaling. Here, we show that the augmented responsiveness of WHIM leukocytes is also accounted for by enhanced βarr2-dependent signaling downstream of the truncated CXCR4 receptor. Indeed, the WHIM-associated receptor CXCR41013 maintains association with βarr2 and triggers augmented and prolonged βarr2-dependent signaling, as revealed by ERK1/2 phosphorylation kinetics. Evidence is also provided that CXCR41013-mediated chemotaxis critically requires βarr2, and disrupting the SHSK motif in the third intracellular loop of CXCR41013 abrogates βarr2-mediated signaling, but not coupling to G proteins, and normalizes chemotaxis. We also demonstrate that CXCR41013 spontaneously forms heterodimers with wild-type CXCR4. Accordingly, we propose a model where enhanced functional interactions between βarr2 and receptor dimers account for the altered responsiveness of WHIM leukocytes to CXCL12.

15 December 2002 in Blood
Verified
Journal Article
Closed access
HGHélène Gary-Gouy
Hélène Gary-Gouy
JHJulie Harriague
Julie Harriague
GBGeorges Bismuth
Georges Bismuth
CPCornelia Platzer
Cornelia Platzer
CSChristian Schmitt
Christian Schmitt
ADAli H. Dalloul
Ali H. Dalloul
CD5 is a negative regulator of B-cell receptor (BCR) signaling that is up-regulated after BCR stimulation and likely contributes to B-cell tolerance in vivo. However, CD5 is constitutively expressed on the B-1 subset of B cells. Contrary to CD5− B-2 B cells, B-1 B cells are long-lived because of autocrine interleukin-10 (IL-10) production through unknown mechanisms. We demonstrate herein a direct relationship between CD5 expression and IL-10 production. Human peripheral blood CD5+ B cells produce more IL-10 than CD5− B cells after BCR activation. Introducing CD5 into CD5− B cells induces the production of IL-10 by activating its promoter and the synthesis of its mRNA. The cytoplasmic domain of CD5 is sufficient for this process. CD5 also protects normal human B cells from apoptosis after BCR stimulation while reducing the BCR-induced Ca2+ response. We conclude that CD5 supports the survival of B cells by stimulating IL-10 production and by concurrently exerting negative feedback on BCR-induced signaling events that can promote cell death.

1 February 2005 in Immunity
Verified
Journal Article
Closed access
DDDavid Depoil
David Depoil
RZRossana Zaru
Rossana Zaru
MGMartine Guiraud
Martine Guiraud
ACAnne Chauveau
Anne Chauveau
JHJulie Harriague
Julie Harriague
SVSalvatore Valitutti
Salvatore Valitutti

21 October 2002 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
JHJulie Harriague
Julie Harriague
GBGeorges Bismuth
Georges Bismuth